Eisai Co., Ltd. (ESALF)
OTCMKTS
· Delayed Price · Currency is USD
28.86
-1.64 (-5.38%)
Mar 10, 2025, 10:59 AM EST
Eisai Employees
Eisai had 11,067 employees as of March 31, 2024. The number of employees decreased by 9 or -0.08% compared to the previous year.
Employees
11,067
Change (1Y)
-9
Growth (1Y)
-0.08%
Revenue / Employee
$454,989
Profits / Employee
$33,789
Market Cap
8.16B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 109 |
Longduoduo Company | 49 |
Eisai News
- 8 days ago - LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer's Treatments| DelveInsight - Benzinga
- 12 days ago - EU regulator not updating opinion on Eisai-Biogen's Alzheimer's drug - Reuters
- 13 days ago - Eisai: Will Have No Problem Hitting Leqembi Forecasts - Seeking Alpha
- 4 weeks ago - Q3 2025 Eisai Co Ltd Earnings Presentation Transcript - GuruFocus
- 4 weeks ago - Eisai projects 42.5B yen global revenue for LEQEMBI in FY2024 amid pathway expansion - Seeking Alpha
- 4 weeks ago - Eisai Co., Ltd. (ESALF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Eisai GAAP EPS of ¥160.14, revenue of ¥601.16B; reaffirms FY outlook - Seeking Alpha
- 5 weeks ago - Europe to review safety data for Eisai-Biogen Alzheimer's drug - Reuters